Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C1q binding and complement activation by prions and amyloids.

Robert B Sim1, Uday Kishore, Christian L Villiers

  • 1MRC Immunochemistry Unit, Department of Biochemistry, Oxford University, South Parks Road, Oxford OX1 3QU, UK. bob.sim@bioch.ox.ac.uk

Immunobiology
|June 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a Standardized Laboratory-Developed Assay for Quantification of BK Virus in Renal Transplant Recipients.

Transplantation proceedings·2026
Same author

Molecular detection and phylogenetic characterization of pathogenic and endosymbiont microorganisms in Hyalomma ticks collected from livestock.

Parasites & vectors·2026
Same author

Expression of Properdin, the positive regulator of the Complement Alternative Pathway, at the fetal-maternal interface in Preeclampsia.

Frontiers in immunology·2026
Same author

Differential expression of complement Properdin and Factor H in the placentae and umbilical cords of mothers with Preeclampsia, Gestational Diabetes Mellitus and Recurrent Pregnancy Loss.

Frontiers in immunology·2026
Same author

Tick threats in the context of climate change: One Health response strategies in the Middle East and North Africa region.

Science in One Health·2026
Same author

Immunobiology of pulmonary fibrosis.

Frontiers in immunology·2025
Same journal

ST2-mediated ERK/JNK/P38/NF-κB signaling: a target of Biminkang mixture in minimal persistent inflammation of allergic rhinitis.

Immunobiology·2026
Same journal

Chronic stress promotes colorectal cancer progression by inducing M2 macrophage polarization and activating the CCL2-CCR2 axis.

Immunobiology·2026
Same journal

Spatial-cellular resolution analysis of ferroptosis-associated immune microenvironment heterogeneity in osteoarthritic cartilage.

Immunobiology·2026
Same journal

Exploring therapeutic targets for neuroinflammation in sepsis-associated encephalopathy: a combined network pharmacology and bioinformatics approach.

Immunobiology·2026
Same journal

Potential correlation assessment identified by a genome-wide association study using induced pluripotent stem cells from patients with IgAN.

Immunobiology·2026
Same journal

MicroRNA-5011-5p attenuates LPS-induced inflammatory damage in periodontal ligament cells by targeting KLF6: an in vitro study.

Immunobiology·2026
See all related articles

Complement protein C1q binds to amyloid materials, contributing to diseases like Alzheimer's. It also interacts with infectious prion proteins, potentially influencing prion disease progression and spread.

Area of Science:

  • Immunology
  • Neuroscience
  • Pathology

Background:

  • The complement system's C1q protein recognizes various self and non-self molecules, including amyloid fibrils.
  • Amyloid deposition and complement activation are implicated in the pathology of diseases like Alzheimer's.
  • Prion diseases involve the misfolding and aggregation of prion proteins (PrP) into amyloid structures.

Purpose of the Study:

  • To explore the role of C1q binding in amyloid diseases and prion diseases.
  • To understand how C1q interaction with prion particles influences disease pathogenesis.

Main Methods:

  • Review of existing literature on C1q interactions with amyloid and prions.
  • Analysis of the proposed mechanisms of complement activation in these diseases.

Related Experiment Videos

Main Results:

  • C1q binding to amyloid fibrils contributes to the pathology of amyloid diseases.
  • Infectious prion particles are likely to bind C1q, activating the complement system.
  • Complement activation may play a role in neuronal damage and prion propagation.

Conclusions:

  • C1q's interaction with amyloid and prion proteins highlights its significance in neurodegenerative and prion diseases.
  • Complement activation influences both the pathology and potentially the infectious cycle of prion diseases.